Insulet Corp. logo
PODDInsulet Corp.

Is the earnings yield high or low?

The earnings yield of 2.89% is 164% above its 5-year average of 1.09%, near the high end of its 5-year range (0.00%–3.09%).

As of Thursday, June 25, 2026. 86.06% above its 12-month average of 1.55%.

PODD Earnings Yield

PODD Earnings Yield Chart

2.89%
+61.45% 1Y
PODD Earnings Yield

PODD Average Earnings Yield Chart

PODD Earnings Yield

PODD Current vs Average Earnings Yield Chart

PODD Earnings Yield Metrics

EARNINGS YIELD

2.89%

EARNINGS YIELD AVG TTM

1.55%

EARNINGS YIELD AVG 3Y

1.57%

EARNINGS YIELD AVG 5Y

1.09%

EARNINGS YIELD AVG 10Y

N/A

EARNINGS YIELD AVG 15Y

N/A

EARNINGS YIELD AVG 20Y

N/A

CURRENT VS TTM AVG

+86.06%

CURRENT VS 3Y AVG

+84.64%

CURRENT VS 5Y AVG

+164.13%

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PODD Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
Insulet Corp. (PODD)$10.31B2.89%1.55%1.57%1.09%
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37BN/A3.00%10.30%8.48%
Baxter International Inc. (BAX)vs ›$10.87BN/A10.19%8.29%5.38%
Charles River Laboratories International, Inc. (CRL)vs ›$9.73BN/A3.32%3.92%3.29%
Henry Schein, Inc. (HSIC)vs ›$9.55B4.00%4.38%4.29%4.75%
Revvity, Inc. (RVTY)vs ›$11.78B1.99%2.31%3.13%3.73%
Align Technology, Inc. (ALGN)vs ›$12.24B3.49%3.52%2.69%2.50%
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.57B2.17%5.66%5.66%16.51%
Oscar Health, Inc. (OSCR)vs ›$7.56BN/A1.67%1.67%1.67%
Solventum Corporation (SOLV)vs ›$13.09B10.81%8.34%8.19%8.19%

Earnings Yield vs P/E Ratio

Earnings Yield

2.89%

EPS ÷ Price

P/E Ratio

34.6

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield FAQ

What is the earnings yield for Insulet Corp. (PODD)?
The earnings yield for PODD stock is 2.89%.
Is Insulet Corp.'s earnings yield high or low?
The earnings yield of 2.89% is 164% above its 5-year average of 1.09%, near the high end of its 5-year range (0.00%–3.09%).
What is the TTM average earnings yield for Insulet Corp. (PODD)?
The TTM average earnings yield for PODD stock is 1.55%.
What is the 3Y average earnings yield for Insulet Corp. (PODD)?
The 3Y average earnings yield for PODD stock is 1.57%.
What is the 5Y average earnings yield for Insulet Corp. (PODD)?
The 5Y average earnings yield for PODD stock is 1.09%.

PODD Earnings Yield History

DATEEARNINGS YIELD
2026-06-242.89%
2026-06-232.99%
2026-06-223.09%
2026-06-182.95%
2026-06-173.00%
2026-06-162.91%
2026-06-152.90%
2026-06-122.87%
2026-06-112.88%
2026-06-102.85%
2026-06-092.69%
2026-06-082.84%
2026-06-052.81%
2026-06-042.94%
2026-06-033.00%
2026-06-023.02%
2026-06-012.90%
2026-05-292.97%
2026-05-283.01%
2026-05-272.94%
2026-05-262.80%
2026-05-222.78%
2026-05-212.74%
2026-05-202.75%
2026-05-192.78%
2026-05-182.82%
2026-05-152.92%
2026-05-142.89%
2026-05-132.89%
2026-05-122.72%
2026-05-112.79%
2026-05-082.79%
2026-05-072.68%
2026-05-062.84%
2026-05-052.09%
2026-05-042.04%
2026-05-012.00%
2026-04-302.03%
2026-04-292.19%
2026-04-281.91%
2026-04-271.86%
2026-04-241.85%
2026-04-231.82%
2026-04-221.81%
2026-04-211.82%
2026-04-201.74%
2026-04-171.72%
2026-04-161.74%
2026-04-151.73%
2026-04-141.74%
2026-04-131.77%
2026-04-101.78%
2026-04-091.76%
2026-04-081.72%
2026-04-071.73%
2026-04-061.72%
2026-04-021.71%
2026-04-011.69%
2026-03-311.67%
2026-03-301.68%
2026-03-271.68%
2026-03-261.60%
2026-03-251.62%
2026-03-241.55%
2026-03-231.54%
2026-03-201.54%
2026-03-191.53%
2026-03-181.52%
2026-03-171.52%
2026-03-161.56%
2026-03-131.59%
2026-03-121.48%
2026-03-111.47%
2026-03-101.47%
2026-03-091.46%
2026-03-061.48%
2026-03-051.45%
2026-03-041.44%
2026-03-031.45%
2026-03-021.43%
2026-02-271.42%
2026-02-261.39%
2026-02-251.41%
2026-02-241.43%
2026-02-231.40%
2026-02-201.45%
2026-02-191.41%
2026-02-181.36%
2026-02-171.40%
2026-02-131.42%
2026-02-121.43%
2026-02-111.38%
2026-02-101.37%
2026-02-091.40%
2026-02-061.43%
2026-02-051.42%
2026-02-041.37%
2026-02-031.37%
2026-02-021.34%
2026-01-301.35%
2026-01-291.35%
2026-01-281.34%
2026-01-271.30%
2026-01-261.27%
2026-01-231.27%
2026-01-221.23%
2026-01-211.21%
2026-01-201.21%
2026-01-161.20%
2026-01-151.20%
2026-01-141.22%
2026-01-131.24%
2026-01-121.24%
2026-01-091.19%
2026-01-081.18%
2026-01-071.15%
2026-01-061.17%
2026-01-051.22%
2026-01-021.22%
2025-12-311.21%
2025-12-301.20%
2025-12-291.20%
2025-12-261.20%
2025-12-241.19%
2025-12-231.21%
2025-12-221.18%
2025-12-191.19%
2025-12-181.18%
2025-12-171.19%
2025-12-161.19%
2025-12-151.18%
2025-12-121.17%
2025-12-111.17%
2025-12-101.17%
2025-12-091.17%
2025-12-081.16%
2025-12-051.13%
2025-12-041.09%
2025-12-031.12%
2025-12-021.12%
2025-12-011.11%
2025-11-281.05%
2025-11-261.06%
2025-11-251.05%
2025-11-241.02%
2025-11-211.04%
2025-11-201.10%
2025-11-191.00%
2025-11-181.03%
2025-11-171.05%
2025-11-141.04%
2025-11-131.04%
2025-11-121.02%
2025-11-111.06%
2025-11-101.08%
2025-11-071.08%
2025-11-061.07%
2025-11-051.05%
2025-11-041.03%
2025-11-031.03%
2025-10-311.05%
2025-10-301.05%
2025-10-291.04%
2025-10-281.01%
2025-10-271.01%
2025-10-241.03%
2025-10-231.02%
2025-10-221.00%
2025-10-211.00%
2025-10-201.01%
2025-10-171.03%
2025-10-161.04%
2025-10-151.05%
2025-10-141.03%
2025-10-131.05%
2025-10-101.05%
2025-10-091.03%
2025-10-081.04%
2025-10-071.05%
2025-10-061.06%
2025-10-031.06%
2025-10-021.05%
2025-10-011.08%
2025-09-301.07%
2025-09-291.06%
2025-09-261.03%
2025-09-251.02%
2025-09-241.01%
2025-09-231.00%
2025-09-220.98%
2025-09-190.99%
2025-09-180.99%
2025-09-171.02%
2025-09-160.99%
2025-09-150.97%
2025-09-120.96%
2025-09-110.97%
2025-09-100.97%
2025-09-090.93%
2025-09-080.94%
2025-09-050.94%
2025-09-040.95%
2025-09-030.96%
2025-09-020.95%
2025-08-290.97%
2025-08-280.97%
2025-08-270.98%
2025-08-260.99%
2025-08-251.00%
2025-08-220.99%
2025-08-211.00%
2025-08-200.99%
2025-08-191.00%
2025-08-181.02%
2025-08-151.02%
2025-08-141.04%
2025-08-131.07%
2025-08-121.06%
2025-08-111.08%
2025-08-081.07%
2025-08-071.08%
2025-08-062.01%
2025-08-051.98%
2025-08-041.93%
2025-08-011.95%
2025-07-311.93%
2025-07-301.86%
2025-07-291.91%
2025-07-281.90%
2025-07-251.92%
2025-07-241.94%
2025-07-231.94%
2025-07-221.95%
2025-07-211.98%
2025-07-181.96%
2025-07-171.96%
2025-07-161.93%
2025-07-151.92%
2025-07-141.90%
2025-07-111.92%
2025-07-101.87%
2025-07-091.87%
2025-07-081.88%
2025-07-071.85%
2025-07-031.85%
2025-07-021.84%
2025-07-011.85%
2025-06-301.77%
2025-06-271.78%
2025-06-261.79%
2025-06-251.82%
2025-06-241.79%
2025-06-231.81%
2025-06-201.83%
2025-06-181.84%
2025-06-171.83%
2025-06-161.81%
2025-06-131.83%
2025-06-121.83%
2025-06-111.84%

Showing the most recent 260 of 1,704 data points. The chart above shows the full history.

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy